Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4085753

CCOC(=O)C(C)CN.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.35
EPHX2 P34913 1/20 0.34
PPARG P37231 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
DPP7 Q9UHL4 2/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP4 P27487 3/20 0.33
CPB2 Q96IY4 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 1/20 0.33
HDAC4 P56524 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
GABRR1 P24046 2/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7391309 0.86
SCHEMBL335271 0.86
Hydrochloric Acid SCHEMBL335270 0.84 ALOX15 (0.44) ALOX15CYP3A4CYP2C19CPB2ALDH1A1
Hydrochloric Acid SCHEMBL7286569 0.84 ALOX15 (0.44) ALOX15CYP3A4CYP2C19CPB2ALDH1A1
Trifluoroacetic Acid SCHEMBL2866762 0.82 CYP3A4 (0.39) ALOX15EPHX2PPARGCYP3A4CYP2C19
Trifluoroacetic Acid SCHEMBL3903912 0.81 ALOX15 (0.35) ALOX15DPP4CPB2ALDH1A1GAA
Trifluoroacetic Acid SCHEMBL1912616 0.81 SMN1; SMN2 (0.38) EPHX2PPARGCYP3A4CYP2C19DPP7
Trifluoroacetic Acid SCHEMBL8465300 0.81 ALOX15 (0.38) ALOX15CYP2C19DPP7DPP8DPP4
Trifluoroacetic Acid SCHEMBL30540777 0.77 CA1 (0.46) CYP1A2HSD17B10
Trifluoroacetic Acid SCHEMBL30179131 0.76 ACE2 (0.45) CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517873-B2 Substituted pyrimidodiazepines HOFFMAN-LA ROCHE INC. (US) 2009-04-14 US disclosed
US-20080234255-A1 SUBSTITUTED PYRIMIDODIAZEPINES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234255-A1 SUBSTITUTED PYRIMIDODIAZEPINES PLK1, CCNI, CDK1 ALOX15 2691/4885EPHX2 3993/4885PPARG 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.